236 related articles for article (PubMed ID: 10235119)
1. Treatment of major depression: is improvement enough?
Ferrier IN
J Clin Psychiatry; 1999; 60 Suppl 6():10-4. PubMed ID: 10235119
[TBL] [Abstract][Full Text] [Related]
2. The patient with comorbid depression and anxiety: the unmet need.
Bakish D
J Clin Psychiatry; 1999; 60 Suppl 6():20-4. PubMed ID: 10235121
[TBL] [Abstract][Full Text] [Related]
3. Redefining antidepressant efficacy toward long-term recovery.
Thase ME
J Clin Psychiatry; 1999; 60 Suppl 6():15-9. PubMed ID: 10235120
[TBL] [Abstract][Full Text] [Related]
4. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
[TBL] [Abstract][Full Text] [Related]
5. Attaining remission in generalized anxiety disorder: venlafaxine extended release comparative data.
Sheehan DV
J Clin Psychiatry; 2001; 62 Suppl 19():26-31. PubMed ID: 11577788
[TBL] [Abstract][Full Text] [Related]
6. Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression.
Nierenberg AA; DeCecco LM
J Clin Psychiatry; 2001; 62 Suppl 16():5-9. PubMed ID: 11480882
[TBL] [Abstract][Full Text] [Related]
7. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
Malhi GS; Ng F; Berk M
Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
Nemeroff CB; Thase ME;
J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158
[TBL] [Abstract][Full Text] [Related]
9. The role of venlafaxine in rational antidepressant therapy.
Feighner JP
J Clin Psychiatry; 1994 Sep; 55 Suppl A():62-8; discussion 69-70, 98-100. PubMed ID: 7961545
[TBL] [Abstract][Full Text] [Related]
10. New developments in the treatment of depression.
Montgomery SA
J Clin Psychiatry; 1999; 60 Suppl 14():10-5; discussion 31-5. PubMed ID: 10408420
[TBL] [Abstract][Full Text] [Related]
11. Evaluating antidepressant therapies: remission as the optimal outcome.
Thase ME
J Clin Psychiatry; 2003; 64 Suppl 13():18-25. PubMed ID: 14552652
[TBL] [Abstract][Full Text] [Related]
12. Venlafaxine extended release versus conventional antidepressants in the remission of depressive disorders after previous antidepressant failure: ARGOS study.
Baldomero EB; Ubago JG; Cercós CL; Ruiloba JV; Calvo CG; López RP
Depress Anxiety; 2005; 22(2):68-76. PubMed ID: 16094658
[TBL] [Abstract][Full Text] [Related]
13. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
[TBL] [Abstract][Full Text] [Related]
14. Treatment of depression--newer pharmacotherapies.
Mulrow CD; Williams JW; Trivedi M; Chiquette E; Aguilar C; Cornell JE; Badgett R; Noël PH; Lawrence V; Lee S; Luther M; Ramirez G; Richardson WS; Stamm K
Psychopharmacol Bull; 1998; 34(4):409-795. PubMed ID: 10513454
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
[TBL] [Abstract][Full Text] [Related]
16. Eighteen months of drug treatment for depression: predicting relapse and recovery.
Mulder RT; Frampton CM; Luty SE; Joyce PR
J Affect Disord; 2009 Apr; 114(1-3):263-70. PubMed ID: 18805590
[TBL] [Abstract][Full Text] [Related]
17. Achieving remission and managing relapse in depression.
Thase ME
J Clin Psychiatry; 2003; 64 Suppl 18():3-7. PubMed ID: 14700448
[TBL] [Abstract][Full Text] [Related]
18. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
Mouchabac S; Ferreri M; Cabanac F; Bitton M
Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
[TBL] [Abstract][Full Text] [Related]
19. Treating depression to remission.
Zajecka JM
J Clin Psychiatry; 2003; 64 Suppl 15():7-12. PubMed ID: 14658985
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project.
Hennings JM; Owashi T; Binder EB; Horstmann S; Menke A; Kloiber S; Dose T; Wollweber B; Spieler D; Messer T; Lutz R; Künzel H; Bierner T; Pollmächer T; Pfister H; Nickel T; Sonntag A; Uhr M; Ising M; Holsboer F; Lucae S
J Psychiatr Res; 2009 Jan; 43(3):215-29. PubMed ID: 18586274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
